Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Flather

Showing results (31-40 of 174) with videos related to

Pageof 18
Sort By:
Pharmacoeconomics|September 17, 2008
Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation modelGuiqing Yao, Nick Freemantle, Marcus Flather, et al.
Age and Ageing|November 8, 2019
New horizons in management of heart failure in older patientsMaria Stefil, Luis Manzano, Manuel Montero-PéRez-Barquero, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|October 28, 2009
Contemporary predictors of coronary artery disease in patients referred for angiographyDipak Kotecha, Marcus Flather, Michele McGrady, et al.
The Cochrane Database of Systematic Reviews|April 5, 2016
WITHDRAWN: Diuretics for heart failureRajaa F Faris, Marcus Flather, Henry Purcell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 5, 2017
Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary InterventionGarry R Barton, Lisa Irvine, Marcus Flather, et al.
Pharmacology & Therapeutics|June 24, 2010
Current strategies in antiplatelet therapy--does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?Tobias Geisler, Meinrad Gawaz, Steven R Steinhubl, et al.
The Heart Surgery Forum|May 13, 2004
Determinants of successful endoscopic internal thoracic artery harvesting: a prospective analysisDouglas West, Eric Lim, Richard Trimlett, et al.
The Cochrane Database of Systematic Reviews|February 17, 2012
Diuretics for heart failureRajaa F Faris, Marcus Flather, Henry Purcell, et al.
Circulation|July 9, 2008
Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS)Jean Booth, Tim Clayton, John Pepper, et al.
Circulation|June 2, 2017
Associations Between Adding a Radial Artery Graft to Single and Bilateral Internal Thoracic Artery Grafts and Outcomes: Insights From the Arterial Revascularization TrialDavid P Taggart, Douglas G Altman, Marcus Flather, et al.
Pageof 18

Showing results (31-40 of 174) with videos related to

Sort By:
Pageof 18
Pharmacoeconomics|September 17, 2008
Long-term cost-effectiveness analysis of nebivolol compared with standard care in elderly patients with heart failure: an individual patient-based simulation modelGuiqing Yao, Nick Freemantle, Marcus Flather, et al.
Age and Ageing|November 8, 2019
New horizons in management of heart failure in older patientsMaria Stefil, Luis Manzano, Manuel Montero-PéRez-Barquero, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|October 28, 2009
Contemporary predictors of coronary artery disease in patients referred for angiographyDipak Kotecha, Marcus Flather, Michele McGrady, et al.
The Cochrane Database of Systematic Reviews|April 5, 2016
WITHDRAWN: Diuretics for heart failureRajaa F Faris, Marcus Flather, Henry Purcell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 5, 2017
Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary InterventionGarry R Barton, Lisa Irvine, Marcus Flather, et al.
Pharmacology & Therapeutics|June 24, 2010
Current strategies in antiplatelet therapy--does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?Tobias Geisler, Meinrad Gawaz, Steven R Steinhubl, et al.
The Heart Surgery Forum|May 13, 2004
Determinants of successful endoscopic internal thoracic artery harvesting: a prospective analysisDouglas West, Eric Lim, Richard Trimlett, et al.
The Cochrane Database of Systematic Reviews|February 17, 2012
Diuretics for heart failureRajaa F Faris, Marcus Flather, Henry Purcell, et al.
Circulation|July 9, 2008
Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS)Jean Booth, Tim Clayton, John Pepper, et al.
Circulation|June 2, 2017
Associations Between Adding a Radial Artery Graft to Single and Bilateral Internal Thoracic Artery Grafts and Outcomes: Insights From the Arterial Revascularization TrialDavid P Taggart, Douglas G Altman, Marcus Flather, et al.
Pageof 18